Overview

Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Status:
Unknown status

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

A study to review Wilson disease patients who have previously been prescribed d- Penicillamine but were changed to trientine as treatment for their disease, and to follow them for a further 12 months.

Phase:

Phase 4

Details

Lead Sponsor:

Univar BV

Treatments:

Penicillamine
Trientine